Ablaze Pharmaceuticals  logo

Ablaze Pharmaceuticals

Leading the Innovative Targeted Radiotherapy Landscape in China.

10 employees · est. 2021 · Shanghai, China

VS
RayzeBio logo

RayzeBio

Targeted innovative radiopharmaceuticals for cancer

258 employees · est. 2020 · San Diego, United States

RayzeBio is the older company (2021 vs 2020); RayzeBio is the larger of the two.

Side-by-Side Comparison

Ablaze Pharmaceuticals RayzeBio
Founded
2021 2020 older
Headquarters
Shanghai, China San Diego, United States
Employees
10 258 larger
Industry
Biotechnology, Pharmaceutical Biotechnology, Health Care, Medical Devices
Funding Stage
Series A Acquired
Total Funding
$75.00M $4.78B
Funding Rounds
1 5
Services
Not tracked yet Development of radiopharmaceutical therapies, Precision cancer treatment using actinium-225, Manufacturing of pharmaceutical products, Clinical trial capabilities, Drug discovery and development
Target Customers
Not tracked yet Cancer patients, Oncologists, Healthcare providers, Research institutions, Pharmaceutical companies
Taxonomy
Pharmaceuticals, Clinical-stage, Radiopharmaceuticals, Cancer Treatment, Targeted Therapy, Drug Development, Partnership, Radiopharmaceutical Company, Cross-border Product Development, Business Networking, China Market, Strategic Partnerships, Healthcare Innovation, Oncology Radiopharmaceuticals, Cancer Treatment, Targeted Therapies, Radioisotopes, Alpha Particles, Actinium-225, Oncology Drug Development, Pipeline Development, Bristol Myers Squibb, Innovative Cancer Solutions, Radiopharmaceutical Leadership, Patient Outcomes, Clinical Advancement, Cancer Treatment Revolution
Website
ablazepharma.com rayzebio.com
Ablaze Pharmaceuticals  logo

About Ablaze Pharmaceuticals

Ablaze Pharmaceuticals is a clinical-stage pharmaceutical company founded in 2011 with a mission to revolutionize the targeted radiotherapy landscape in China. The company has garnered attention for its partnership with RayzeBio, Inc., a leading radiopharmaceutical firm based in San Diego, CA. This...

RayzeBio logo

About RayzeBio

RayzeBio, founded in 2020, is a cutting-edge player in the Biotechnology and Pharmaceutical sectors, focusing on the development of targeted innovative radiopharmaceuticals for cancer treatment. With a mission outlined in their slogan, "Targeted innovative radiopharmaceuticals for cancer," RayzeBio...

We will tell you when either one moves

BounceWatch watches Ablaze Pharmaceuticals and RayzeBio for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Ablaze Pharmaceuticals... and RayzeBio — by email.

Frequently Asked Questions

Ablaze Pharmaceuticals — Leading the Innovative Targeted Radiotherapy Landscape in China. . RayzeBio — Targeted innovative radiopharmaceuticals for cancer. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Ablaze Pharmaceuticals has raised $75.00M while RayzeBio has raised $4.78B.
Ablaze Pharmaceuticals and RayzeBio operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Ablaze Pharmaceuticals with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Ablaze Pharmaceuticals on 12 Sep 2024, and RayzeBio on 28 Jan 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy